Guidewires Market to Reach USD 1,401.0 Million at 5.9% CAGR by 2026; Growing Rate of Coronary Surgeries to Bolster Sales Opportunities: Fortune Business Insights

NEXT STORY
BeyondSpring Announces Data & Safety Monitoring Board Recommendation for Plinabulin to Continue NSCLC Phase 3 Dublin-3 Study Without Modification
PREV STORY
ChemoCentryx Phase III ADVOCATE Trial of Avacopan in ANCA-Associated Vasculitis Highlighted in Oral Plenary Presentations at EULAR and ERA-EDTA Congresses
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Basilea reports presentation of data on clinical oncology programs BAL101553 and BAL3833 at AACR meeting

Tumor checkpoint controller BAL101553 demonstrates pre-clinical activity in treatment-refractory glioblastoma models as single agent ...

author_avatar
NASDAQ Market News

Revolo Biotherapeutics Activates Clinical Trial and Commences Enrollment in Phase 2 Clinical Study of ‘1104 in Allergic Disease in the UK

author_avatar
NASDAQ Market News

Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2019 Financial Results

author_avatar
NASDAQ Market News